105 related articles for article (PubMed ID: 3497436)
1. Trimethoprim used for selective decontamination of the digestive tract in rats: possible route of excretion.
Toorop-Bouma AG; van der Waaij D
Scand J Infect Dis; 1987; 19(3):361-7. PubMed ID: 3497436
[TBL] [Abstract][Full Text] [Related]
2. Selective elimination of Enterobacteriaceae species from the digestive tract in mice and rats.
Koopman JP; Kennis HM; Stadhouders AM; de Boer H
Z Versuchstierkd; 1984; 26(5):197-204. PubMed ID: 6334949
[No Abstract] [Full Text] [Related]
3. Selective decontamination of the digestive tract of pregnant rabbits: a method for producing Enterobacteriaceae-free rabbits.
Heidt PJ; Timmermans CP
Lab Anim Sci; 1975 Oct; 25(5):594-6. PubMed ID: 127074
[TBL] [Abstract][Full Text] [Related]
4. [Present status of the resistance of enterobacteria to the combination of a sulfonamide and trimethoprim].
Riou B; Richard C; Rimailho A; Bottineau G; Coquin Y; Auzepy P
Presse Med; 1984 Jun; 13(26):1637-8. PubMed ID: 6234571
[No Abstract] [Full Text] [Related]
5. Comparison of a novel trimethoprim-sulfamethoxazole-containing medium (XT80) with kanamycin agar for isolation of antibiotic-resistant organisms from stool and rectal cultures of marrow transplant patients.
Hamilton DJ; Ulness BK; Baugher LK; Counts GW
J Clin Microbiol; 1987 Oct; 25(10):1886-90. PubMed ID: 3312287
[TBL] [Abstract][Full Text] [Related]
6. Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients.
Wells CL; Podzorski RP; Peterson PK; Ramsay NK; Simmons RL; Rhame FS
J Infect Dis; 1984 Nov; 150(5):699-706. PubMed ID: 6387000
[TBL] [Abstract][Full Text] [Related]
7. Selective elimination of Enterobacteriaceae from the digestive tract in rats with trimethoprim.
Koopman JP; Kennis HM; Stadhouders AM; de Boer H; Hectors MP
Z Versuchstierkd; 1985; 27(3-4):143-8. PubMed ID: 4050161
[No Abstract] [Full Text] [Related]
8. Trimethoprim-sulfamethoxazole for bacterial meningitis.
Levitz RE; Quintiliani R
Ann Intern Med; 1984 Jun; 100(6):881-90. PubMed ID: 6372565
[TBL] [Abstract][Full Text] [Related]
9. Effect of trimethoprim on the occurrence of drug-resistant coliform bacteria in the faecal flora.
Toivanen A; Kasan A; Sundquist H; Toivanen P
Chemotherapy; 1976; 22(2):97-103. PubMed ID: 1253636
[TBL] [Abstract][Full Text] [Related]
10. Binding to faeces and influence on human anaerobes of antimicrobial agents used for selective decontamination.
Hazenberg MP; Van de Boom M; Bakker M; Van de Merwe JP
Antonie Van Leeuwenhoek; 1983 Jun; 49(2):111-7. PubMed ID: 6351739
[TBL] [Abstract][Full Text] [Related]
11. Co-trimoxazole resistance in Jamaica.
Macfarlane DE
Lancet; 1986 Apr; 1(8486):923. PubMed ID: 2870396
[No Abstract] [Full Text] [Related]
12. Influence of cefaclor, phenethicillin, co-trimoxazole and doxycycline on colonization resistance in healthy volunteers.
Vollaard EJ; Clasener HA; van Griethuysen AJ; Janssen AJ; Sanders-Reijmers AH; Muller NF; Huige PJ
J Antimicrob Chemother; 1988 Nov; 22(5):747-58. PubMed ID: 3145269
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of cefetamet (Ro 15-8074).
Mittermayer H
Eur J Clin Microbiol; 1986 Oct; 5(5):530-4. PubMed ID: 3490975
[No Abstract] [Full Text] [Related]
14. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
Unal S; Aydin M; Akin A
Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
[TBL] [Abstract][Full Text] [Related]
15. Trimethoprim-sulfamethoxazole.
Rubin RH; Swartz MN
N Engl J Med; 1980 Aug; 303(8):426-32. PubMed ID: 6967184
[No Abstract] [Full Text] [Related]
16. Therapeutic progress: trimethoprim-sulfamethoxazole.
Ruiz López R; Saavedra S; Ramírez-Ronda CH
Bol Asoc Med P R; 1984 Jul; 76(7):309-13. PubMed ID: 6332635
[No Abstract] [Full Text] [Related]
17. Infection caused by thymidine-requiring, trimethoprim-resistant bacteria.
King CH; Shlaes DM; Dul MJ
J Clin Microbiol; 1983 Jul; 18(1):79-83. PubMed ID: 6604070
[TBL] [Abstract][Full Text] [Related]
18. The effect of cotrimoxazole on the absorption of orally administered 6-mercaptopurine in the rat.
Burton NK; Aherne GW
Cancer Chemother Pharmacol; 1986; 16(1):83-4. PubMed ID: 3484383
[TBL] [Abstract][Full Text] [Related]
19. The effect of a combined preparation of trimethoprim and sulphamethoxazole following short-term and long-term administration on the flora of the human gut.
Knothe H
Chemotherapy; 1973; 18(5):285-96. PubMed ID: 4199490
[No Abstract] [Full Text] [Related]
20. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
Murray BE; Rensimer ER; DuPont HL
N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
